InsiderClue
← All stocks

RxSight, Inc.

RXST Net selling
CIK 0001111485 #3743 in the set updated 17 Sep 2026
Bought (120 mo)
$23.43M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$63.11M
$15.60M on a plan · $15.20M straight out of an exercise
Sold at will
$32.31M
17 of 129 sales
Net
−$39.68M
−$8.88M against sales at will

By person

19 insiders · 171 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Tammenoms Bakker Juliet
Director
$16.91M (7)
$30.74M (10)
−$13.82M
586,731
1.41%
$4.08M
+17.3%
Thunen Shelley B
See remarks
—
$8.54M (26) scheduled
−$8.54M
38,354
0.0922%
$266.94K
−24.5%
Goldshleger Ilya
Chief Operating Officer
$33.27K (2)
$8.03M (60) scheduled
−$8.00M
82,881
0.1993%
$576.85K
—
Kurtz Ronald M MD
Chief Medical Officer
$2.05M (2)
$7.72M (7) scheduled
−$5.67M
1,600,995
3.85%
$11.14M
+2.3%
Corley Jesse Anderson
Director
$2.47M (8)
$571.53K (3) scheduled
+$1.89M
525,638
1.26%
$3.66M
+78.6%
Weinberg Eric
See remarks
$515.24K (6)
$2.27M (7) scheduled
−$1.76M
837,322
2.01%
$5.83M
+33.2%
Warner Robert Keith
Director
$700.00K (1)
$1.71M (4) scheduled
−$1.01M
135,204
0.3251%
$941.02K
+136.7%
Maniar Shweta
Director
—
$983.95K (6) scheduled
−$983.95K
55,172
0.1326%
$384.00K
—
LINK WILLIAM J PHD
Director
$500.00K (1)
$1.40M (2)
−$903.12K
2,112,918
5.08%
$14.71M
−7.0%
Andrews Julie
Director
$250.00K (1)
$906.29K (2) scheduled
−$656.29K
78,076
0.1877%
$543.41K
—
Fountain Tamara
Director
—
$180.00K (1) scheduled
−$180.00K
72,582
0.1745%
$505.17K
—
Wilterding Mark
Chief Financial Officer
—
$54.04K (1)
−$54.04K
25,049
0.0602%
$174.34K
—
RxSight I, LLC entity
10% owner
—
—
—
2,016,778
4.85%
$14.04M
—
Wolfen Richard M.
Director
—
—
—
1,840,244
4.42%
$12.81M
+572.9%
Robertson Bruce C
Director
—
—
—
1,385,037
3.33%
$9.64M
—
Schwartz Daniel Mark
Director
—
—
—
407,647
0.9801%
$2.84M
+1.0%
PALMISANO ROBERT J
Director
—
—
—
78,076
0.1877%
$543.41K
—
COHEN RAYMOND W
Director
—
—
—
66,532
0.1600%
$463.06K
—
Gaines Scott
Chief Customer Officer
—
—
—
14,848
0.0357%
$103.34K
+33.0%

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Weinberg Eric
2 Sep 2026
See remarks
Sell
2,041
$6.96
$14.21K
Goldshleger Ilya
2 Sep 2026
Chief Operating Officer
Sell
2,041
$6.96
$14.21K
Wilterding Mark
2 Sep 2026
Chief Financial Officer
Sell
7,765
$6.96
$54.04K
Kurtz Ronald M MD
2 Sep 2026
Chief Medical Officer
Sell
5,100
$6.96
$35.50K
LINK WILLIAM J PHD
1 Feb 2024
Director
Sell indirect
7,652
$50.01
$382.66K
LINK WILLIAM J PHD
1 Feb 2024
Director
Sell indirect
20,598
$49.54
$1.02M
Weinberg Eric
22 Dec 2023
Chief Commercial Officer
Sell indirect
1,285
$40.00
$51.40K
Tammenoms Bakker Juliet
29 Nov 2023
Director
Sell indirect
349,245
$29.77
$10.40M
Tammenoms Bakker Juliet
28 Nov 2023
Director
Sell indirect
145,068
$29.62
$4.30M
Tammenoms Bakker Juliet
15 Nov 2023
Director
Sell indirect
400,000
$27.20
$10.88M
Tammenoms Bakker Juliet
14 Nov 2023
Director
Sell indirect
100,000
$27.13
$2.71M
Tammenoms Bakker Juliet
11 Sep 2023
Director
Sell
2,950
$30.01
$88.52K
Tammenoms Bakker Juliet
8 Sep 2023
Director
Sell
10,033
$30.25
$303.46K
Tammenoms Bakker Juliet
7 Sep 2023
Director
Sell
19,967
$30.10
$600.98K
Tammenoms Bakker Juliet
25 Aug 2023
Director
Sell
16,208
$29.25
$474.13K
Tammenoms Bakker Juliet
18 Aug 2023
Director
Sell
14,651
$29.07
$425.88K
Tammenoms Bakker Juliet
17 Aug 2023
Director
Sell
18,484
$30.06
$555.69K
Show all 171 transactions →

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 39
Sales straight out of an exercise 73
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 15,865,409
History held since 2 Aug 2021